Search research articles
Contact Us
Filters
Showing results (311-320 of 325) with videos related to
Page
of 33
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 8, 2021
Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease
Paul M Lantos, Jeffrey Rumbaugh, Linda K Bockenstedt, et al.
Neurology
|
December 1, 2020
Clinical Practice Guidelines by the Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology: 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease
Paul M Lantos, Jeffrey Rumbaugh, Linda K Bockenstedt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 23, 2021
Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease
Paul M Lantos, Jeffrey Rumbaugh, Linda K Bockenstedt, et al.
Annals of Clinical and Translational Neurology
|
September 18, 2025
A Multi-Center Retrospective Cohort Study of Neurosarcoidosis Myelitis: Current Observations and Future Directions
Giovanna S Manzano, Denis Balaban, Yihan Zhang, et al.
The Journal of Prevention of Alzheimer'S Disease
|
May 6, 2024
Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical Trials
H Liu, J Li, E Ziegemeier, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 5, 2023
Longitudinal head-to-head comparison of <sup>11</sup>C-PiB and <sup>18</sup>F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's disease
Charles D Chen, Austin McCullough, Brian Gordon, et al.
JAMA Neurology
|
April 29, 2024
Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial
Olivia Wagemann, Haiyan Liu, Guoqiao Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 15, 2025
Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial
Austin McCullough, Charles D Chen, Brian A Gordon, et al.
Brain : a Journal of Neurology
|
June 18, 2026
Long-term prognosis of patients surviving progressive multifocal leukoencephalopathy
Nicolas Lambert, Majdouline El Moussaoui, Adèle Le Guilloux, et al.
Annals of Neurology
|
September 24, 2022
Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease
Nelly Joseph-Mathurin, Jorge J Llibre-Guerra, Yan Li, et al.
Page
of 33
Search research articles
Search
Showing results (311-320 of 325) with videos related to
Sort By:
Page
of 33
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 8, 2021
Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease
Paul M Lantos, Jeffrey Rumbaugh, Linda K Bockenstedt, et al.
Neurology
|
December 1, 2020
Clinical Practice Guidelines by the Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology: 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease
Paul M Lantos, Jeffrey Rumbaugh, Linda K Bockenstedt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 23, 2021
Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease
Paul M Lantos, Jeffrey Rumbaugh, Linda K Bockenstedt, et al.
Annals of Clinical and Translational Neurology
|
September 18, 2025
A Multi-Center Retrospective Cohort Study of Neurosarcoidosis Myelitis: Current Observations and Future Directions
Giovanna S Manzano, Denis Balaban, Yihan Zhang, et al.
The Journal of Prevention of Alzheimer'S Disease
|
May 6, 2024
Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical Trials
H Liu, J Li, E Ziegemeier, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 5, 2023
Longitudinal head-to-head comparison of <sup>11</sup>C-PiB and <sup>18</sup>F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's disease
Charles D Chen, Austin McCullough, Brian Gordon, et al.
JAMA Neurology
|
April 29, 2024
Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial
Olivia Wagemann, Haiyan Liu, Guoqiao Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 15, 2025
Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial
Austin McCullough, Charles D Chen, Brian A Gordon, et al.
Brain : a Journal of Neurology
|
June 18, 2026
Long-term prognosis of patients surviving progressive multifocal leukoencephalopathy
Nicolas Lambert, Majdouline El Moussaoui, Adèle Le Guilloux, et al.
Annals of Neurology
|
September 24, 2022
Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease
Nelly Joseph-Mathurin, Jorge J Llibre-Guerra, Yan Li, et al.
Page
of 33